ESMO 2022 Conference Coverage


 

Lecture Summary - ESMO 2022 Updates on the Randomized Phase III VANCE Study: Gem & Carbo Followed by Epstein-Barr Virus-Specific Autologous Cytotoxic T-Lymphocytes vs. the Same Chemo as 1L Treatment for Advanced Nasopharyngeal Carcinoma

4 views
September 22, 2022
0 Comments
Login to view comments. Click here to Login
Head and Neck